Skyhawk Therapeutics

Skyhawk Therapeutics

  • Founded: 2018
  • Location: Waltham, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin0
  • Therapy area: Neurodegenerative condition
  • Drug types: NEU, ONC, MUS, IMM
  • Lead product: Undisclosed
  • Product link: https://skyhawktx.com/our-pipeline/
  • Funding: $133M Sep 2021; $40M A Jul 2018; $8M seed Jan 2018


skyhawktx.com

linkedin.com

job board


Short description:

RNA-correcting Small Molecules

Drug notes:

16 additional undisclosed programs RD/Clin0 autoimmune conditions, oncology, muscular & neuromuscular conditions, neurodegenerative conditions

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com